Due to a production error, there was a mistake in Figure 1 as published. The wrong figure was inserted as Figure 1 . The corrected Figure 1 appears below. The publisher apologizes for this mistake.
Erratum: Assessment of plasma Catestatin in COVID-19 reveals a hitherto unknown inflammatory activity with impact on morbidity-mortality
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
*Correspondence: Frontiers Production Office, production.office@frontiersin.org
This article was submitted to Molecular Innate Immunity, a section of the journal Frontiers in Immunology
Received 2022 Nov 14; Accepted 2022 Nov 14; Collection date 2022.
Keywords: Innate immunity, COVID, Catestatin, Chromogranin A, hypoxia, critically ill, nosocomial disease
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.